Mahamaya Lifesciences’ Rs 70.44 crore IPO opens Tuesday, aiming to raise funds for a new manufacturing plant and equipment. Despite a cautious grey market, the company reported strong revenue and profit growth in FY25. The IPO structure includes fresh issue and offer for sale, with allocations for QIBs, NIIs, and retail investors.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets